Evidence map›Paper›PMID 29855274›Full record

ArticleBMC infectious diseases2018

Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.

Ye Zhang, Ling-Yun Guo, Wen-Qi Song, Yan Wang, Fang Dong, Gang Liu

Abstract read
In one paragraph

Article in BMC infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Risk factors for the colonization or infection of carbapenem-resistantZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2022
    Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. [Clinical and molecular characteristics of neonatalZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Article
  8. Regional surveillance of carbapenem-resistantFrontiers in cellular and infection microbiology · 2026
    Article
  9. Article
  10. Observational
  11. Lessons from Four Years (2021-2024) ofAntibiotics (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Article
  14. Characterization of carbapenem-resistantFrontiers in cellular and infection microbiology · 2025
    Article
  15. Article
  16. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2024
    Review
  17. Article
  18. Observational
  19. The Influences of the COVID-19 Pandemic onIndian journal of microbiology · 2024
    Article
  20. Plant-Origin Components: New Players to Combat Antibiotic Resistance inInternational journal of molecular sciences · 2024
    Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ye ZhangDepartment of Infectious Disease, Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Road, Xi Cheng District, Beijing, 100045, People's Republic of China.
Ling-Yun GuoDepartment of Infectious Disease, Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Road, Xi Cheng District, Beijing, 100045, People's Republic of China.
Wen-Qi SongDepartment of Laboratory Medicine, Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Road, Xi Cheng District, Beijing, 100045, People's Republic of China.
Yan WangDepartment of Laboratory Medicine, Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Road, Xi Cheng District, Beijing, 100045, People's Republic of China.
Fang DongDepartment of Laboratory Medicine, Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Road, Xi Cheng District, Beijing, 100045, People's Republic of China. fangd32@163.com.
Gang LiuDepartment of Infectious Disease, Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Road, Xi Cheng District, Beijing, 100045, People's Republic of China. liugangbch@sina.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBloodstream infections (BSI) caused by carbapenem-resistant K. pneumoniae (CRKP) are associated with high rates of morbidity and mortality. Early identification of patients at highest risk is very important. The aim of this study was to describe the clinical characteristics and mortality of K. pneumoniae BSI and to identify risk factors associated with CRKP BSI among paediatric patients.

methodsFrom January 2011 to December 2014, a retrospective case-control study was conducted at Beijing Children's Hospital, China. Risk factors for CRKP BSI and for K. pneumoniae BSI-related death were evaluated. Patients with BSI caused by K. pneumoniae were identified from the microbiology laboratory database. Data regarding demographic, microbiological and clinical characteristics, therapy and outcome were collected from the medical records.

resultsA total of 138 patients with K. pneumoniae BSI were enrolled, including 54 patients with CRKP BSI and 84 patients with carbapenem-susceptible K. pneumoniae (CSKP) BSI. Most of the BSI (114; 82.6%) were healthcare-associated, while the rest (24; 17.4%) were community-acquired. Hematologic malignancies (odds ratio (OR):4.712, [95% CI: 2.181-10.180], P <  0.001) and previous cephalosporin administration (OR: 3.427, [95% CI: 1.513-7.766], P = 0.003) were found to be associated with the development of CRKP BSI. 28-day mortality of K. pneumoniae BSI was 8.7%. Mechanical ventilation (OR:9.502, [95% CI: 2.098-43.033], P = 0.003), septic shock (OR:6.418, [95% CI: 1.342-30.686], P = 0.020), and isolation of CRKP (OR:9.171, [95% CI: 1.546-54.416], P = 0.015) were independent risk factors for 28-day mortality of K. pneumoniae BSI.

conclusionHematologic malignancies and previous cephalosporin administration were associated with the development of CRKP BSI, while mechanical ventilation, septic shock and CRKP infection were independent mortality predictors for K. pneumoniae BSI. More attention should be paid to CRKP BSI in the paediatric population.

Indexed as

Drug Resistance, Multiple, BacterialAdolescentAnti-Bacterial AgentsBacteremiaCarbapenemsCase-Control StudiesChildChild MortalityChild, PreschoolChinaFemaleHumansInfantInfant, NewbornKlebsiella InfectionsKlebsiella pneumoniaeAnti-Bacterial AgentsCarbapenemsBloodstream infectionCarbapenem-resistant K. pneumoniaeChildrenRisk factor

Identifiers

PMID29855274
PMCPMC5984460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.